These data confirmed that the KF9 epitope is immunodominant in convalescent HLA-C*12:02+ samples at 6–12 months after infection, but the phenotype of the proliferating KF9/C12-specific T cells was altered between 6- and 12-month post-infection. This evidence concerns the gene HLA-C and infection.